Insider Transactions in Q2 2019 at Crispr Therapeutics Ag (CRSP)
Insider Transaction List (Q2 2019)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 17
2019
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,000
-10.76%
|
$920,000
$46.0 P/Share
|
Jun 17
2019
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+9.72%
|
$20,000
$1.81 P/Share
|
Jun 10
2019
|
Rodger Novak President |
SELL
Open market or private sale
|
Direct |
50,000
-5.27%
|
$2,250,000
$45.0 P/Share
|
Jun 01
2019
|
Samarth Kulkarni Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
741
-0.44%
|
$25,935
$35.57 P/Share
|
Apr 29
2019
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,000
-10.72%
|
$840,000
$42.03 P/Share
|
Apr 29
2019
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+9.68%
|
$20,000
$1.81 P/Share
|